Norstella and Citeline Merge to Create $5B Global Pharma Technology Company

Norstella Formed by Uniting Evaluate, MMIT, Panalgo and The Dedham Group

May 3, 2022

Healthcare Services

Four life‑sciences solutions providers — Evaluate, MMIT, Panalgo and The Dedham Group — have united under the new organization Norstella to combine data, analytics, software and market‑access consulting to speed patient access to therapies. The move creates an integrated platform offering commercial intelligence, market access insights and healthcare analytics to pharmaceutical manufacturers and other life‑sciences customers.

NLS Pharmaceutics Merges with Kadimastem to Form NewCelX

June 27, 2025

Biotechnology

NLS Pharmaceutics Ltd. completed a $3.0 million equity financing to support its pending merger with Kadimastem Ltd.; the transaction closed and the combined company was re-named NewCelX Ltd. The deal brings together NLS's CNS-focused pipeline and Kadimastem's cell therapy programs (AstroRx and IsletRx) to advance clinical development for ALS, diabetes and other regenerative-medicine indications.

Nordic Capital and Astorg Acquire Cytel from New Mountain Capital

December 21, 2020

Healthcare Services

Nordic Capital and Astorg have agreed to jointly acquire Cytel Inc. from New Mountain Capital. Cytel, a Waltham, Massachusetts–based provider of clinical trial design software, biometrics services and advanced analytics with more than 1,500 employees, will continue to be led by CEO Josh Schultz while the new owners invest to accelerate product development and growth; terms were not disclosed.

Warburg Pincus and Mubadala Acquire Pharma Intelligence from Informa

June 1, 2022

Data & Analytics

Warburg Pincus, joined by Mubadala Investment Company, completed the acquisition of Pharma Intelligence (the Citeline suite and related specialist brands) from Informa PLC, with Informa retaining a 15% equity stake. The investors said they will invest in product development and innovation to expand Pharma Intelligence's position in the pharmaceutical data and analytics market; Jay Nadler was appointed Executive Chair following completion.

Elligo Health Research Acquires ClinEdge in $135M Transaction

September 23, 2021

Healthcare Services

Elligo Health Research completed the acquisition of ClinEdge (including GuideStar Research and BTC of New Bedford) as part of a $135 million financing led by Morgan Stanley Expansion Capital and Ally Bridge Group, with participation from Norwest Venture Partners and existing investors. The deal expands Elligo’s global scale and capabilities by combining ClinEdge’s research practice management and clinical services with Elligo’s IntElligo technology, EHR-derived data access, and trial-acceleration platform.

ERT Merges with Bioclinica to Create Global Clinical Trial Endpoint Leader

December 10, 2020

Healthcare Services

ERT has merged with Bioclinica to create a global leader in clinical trial endpoint technology, combining Bioclinica's imaging and eClinical capabilities with ERT's expertise in eCOA, cardiac safety, respiratory and wearables. The transaction was completed in 2021 with Cinven (Bioclinica's owner) becoming a significant minority shareholder in ERT alongside Nordic Capital, Astorg and Novo Holdings A/S.